Correction to: Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y)

Kelly G. Knupp, Elaine C Wirrell

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

Page 335, Abstract: The sentence that read: Benefit has also been noted with topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation. Should read: Benefit has also been noted with stiripentol, topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation.

Original languageEnglish (US)
JournalCNS Drugs
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

etiracetam
Ketogenic Diet
Myoclonic Epilepsy
Vagus Nerve Stimulation
Pharmaceutical Preparations
Therapeutics
topiramate

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Correction to : Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y). / Knupp, Kelly G.; Wirrell, Elaine C.

In: CNS Drugs, 01.01.2018.

Research output: Contribution to journal › Article

Knupp, KG & Wirrell, EC 2018, 'Correction to: Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y)', CNS Drugs. https://doi.org/10.1007/s40263-018-0546-0
Knupp KG, Wirrell EC. Correction to: Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y). CNS Drugs. 2018 Jan 1. https://doi.org/10.1007/s40263-018-0546-0
Knupp, Kelly G. ; Wirrell, Elaine C. / Correction to : Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y). In: CNS Drugs. 2018.
@article{80e41bd7c5bf40089bf9ab273d9ee1da,
title = "Correction to: Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y)",
abstract = "Page 335, Abstract: The sentence that read: Benefit has also been noted with topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation. Should read: Benefit has also been noted with stiripentol, topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation.",
author = "Knupp, {Kelly G.} and Wirrell, {Elaine C}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s40263-018-0546-0",
language = "English (US)",
journal = "CNS Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Correction to

T2 - Treatment Strategies for Dravet Syndrome (CNS Drugs, (2018), 32, 4, (335-350), 10.1007/s40263-018-0511-y)

AU - Knupp, Kelly G.

AU - Wirrell, Elaine C

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Page 335, Abstract: The sentence that read: Benefit has also been noted with topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation. Should read: Benefit has also been noted with stiripentol, topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation.

AB - Page 335, Abstract: The sentence that read: Benefit has also been noted with topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation. Should read: Benefit has also been noted with stiripentol, topiramate, levetiracetam, the ketogenic diet and vagal nerve stimulation.

UR - http://www.scopus.com/inward/record.url?scp=85050292034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050292034&partnerID=8YFLogxK

U2 - 10.1007/s40263-018-0546-0

DO - 10.1007/s40263-018-0546-0

M3 - Article

C2 - 30027402

AN - SCOPUS:85050292034

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

ER -

Access to Document